시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 5세대 DNA 시퀀싱 시장 분석 및 예측(-2034년) : 유형, 제품, 서비스, 기술, 컴포넌트, 용도, 최종 사용자, 장치, 프로세스, 단계별
5th Generation DNA Sequencing Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, End User, Device, Process, Stage
상품코드 : 1740715
리서치사 : Global Insight Services LLC
발행일 : 2025년 06월
페이지 정보 : 영문 321 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ￦ 6,517,000
Single User License help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능하며, 인쇄는 가능합니다.
US $ 5,750 ￦ 7,889,000
Site License help
PDF, Excel 보고서를 동일 기업(국가)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,750 ￦ 9,261,000
Enterprise License help
PDF, Excel 보고서를 동일 기업의 전 세계 모든분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 5세대 DNA 시퀀싱은 2024년 42억 달러에서 2034년까지 158억 달러로 확대되어 약 14.2%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. AI와 클라우드 컴퓨팅의 통합으로 건강 관리, 농업, 바이오테크놀러지에 대한 유전학적 통찰에 대한 수요 증가를 배경으로 이 시장은 크게 성장할 전망입니다.

시장 개요:

5세대 DNA 시퀀싱 시장은 주로 정밀의료 및 개인화 건강 관리의 진보로 급속한 확장을 경험하고 있습니다. 주요 시장 부문에는 장비, 소모품, 서비스 및 소프트웨어가 포함됩니다. 부족한 시퀀싱 키트 및 시약의 지속적인 수요로 인해 주요 부문으로 부상하고 있습니다. 감소하는 혁신적인 소모품의 지속적인 개발로 시장에서의 지위가 높아지고 있습니다. 이러한 부문은 POC(Point of Care) 진단 및 현장 기반 유전체 연구에 혁명을 일으킬 수 있어 시장의 범위와 적용성을 확대합니다.

주요 동향 및 촉진요인:

5세대 DNA 시퀀싱은 기술 진보와 정밀의료에 대한 수요 증가에 힘입어 강력한 확장을 경험하고 있습니다. 주요 동향은 인공지능의 통합으로 데이터 분석 및 해석을 강화하고 보다 정확하고 효율적인 시퀀싱 결과를 제공합니다. 시퀀싱 비용의 저하로 폭넓은 연구기관이나 임상 현장이 기술을 이용할 수 있게 되어 보급이 가속되고 있습니다. 맞춤형 의료의 대두는 중요한 촉진요인이며, 개별 환자에 맞춘 치료를 실시하기 위해서는 정확한 유전자 정보가 필요하기 때문입니다. 이 수요는 DNA 시퀀싱 기술에 대한 R&D 투자를 뒷받침하고 있습니다. 게다가 유전성 질환과 암 유병률 증가는 고급 시퀀싱 솔루션에 대한 요구를 강화하고 시장 성장을 더욱 자극하고 있습니다. 헬스케어 인프라가 급속히 발전하고 있는 신흥국 시장에는 개발 기회가 풍부합니다. 합리적인 가격으로 확장 가능한 시퀀싱 솔루션을 제공할 수 있는 기업은 이러한 지역에서 시장 점유율을 얻는 데 유리한 위치에 있습니다. 게다가 학술기관과 업계 기업의 협업이 혁신을 촉진하고 차세대 시퀀싱 플랫폼 개발을 추진하고 있습니다. 헬스케어에서 유전체학의 중시가 진행되고 있는 가운데, 5세대 DNA 시퀀싱은 지속적인 성장을 이룰 것입니다.

주요 억제요인과 도전:

5세대 DNA 시퀀싱은 여러 가지 현저한 억제요인과 과제에 직면하고 있습니다. 기술이 요구되고 시퀀싱 결과의 실용화에서 병목 현상이 되고 있습니다. 또한 데이터의 프라이버시와 보안에 대한 우려는 잠재적인 이용자의 족쇄가 됩니다. 지속적인 투자와 적응이 필요하며, 이것은 많은 조직에 어려운 전망이 될 수 있습니다.

목차

1장 5세대 DNA 시퀀싱 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 제5세대 DNA 시퀀싱의 전망

제5장 제5세대 DNA 시퀀싱 전략

제6장 5세대 DNA 시퀀싱 시장 규모

제7장 유형별

제8장 제품별

제9장 서비스별

제10장 기술별

제11장 컴포넌트별

제12장 용도별

제13장 최종 사용자별

제14장 장치별

제15장 프로세스별

제16장 단계별

제17장 지역별

제18장 경쟁 구도

제19장 기업 프로파일

JHS
영문 목차

영문목차

5th Generation DNA Sequencing Market is anticipated to expand from $4.2 billion in 2024 to $15.8 billion by 2034, growing at a CAGR of approximately 14.2%. The market encompasses advanced technologies enabling rapid, precise, and cost-effective genomic analysis. These innovations facilitate real-time sequencing, enhancing applications in personalized medicine, diagnostics, and research. With the integration of AI and cloud computing, this market is poised for significant growth, driven by the increasing demand for genetic insights in healthcare, agriculture, and biotechnology. The focus on miniaturization and portability of sequencers further expands accessibility, promising transformative impacts on disease understanding and treatment.

Market Overview:

The 5th Generation DNA Sequencing Market is experiencing rapid expansion, primarily driven by advancements in precision medicine and personalized healthcare. The key market segments include instruments, consumables, services, and software. The consumables segment emerges as the leading segment, owing to the recurring demand for sequencing kits and reagents essential for high-throughput sequencing processes. This dominance is propelled by the increasing adoption of sequencing technologies in clinical diagnostics and research applications. Moreover, the continuous development of innovative consumables that improve accuracy and reduce sequencing costs enhances its market position. Emerging sub-segments such as portable sequencing devices and real-time sequencing services are gaining traction, offering unprecedented convenience and speed. These sub-segments have the potential to revolutionize point-of-care diagnostics and field-based genomic studies, thus expanding the market's reach and applicability. The integration of AI and machine learning in sequencing software also presents transformative opportunities, enhancing data interpretation and predictive analytics.

Market Segmentation
TypeWhole Genome Sequencing, Targeted Sequencing, Exome Sequencing, RNA Sequencing, Epigenomic Sequencing, De Novo Sequencing, Metagenomic Sequencing
ProductSequencing Instruments, Sequencing Kits, Consumables
ServicesSequencing Services, Data Analysis Services, Consultation Services
TechnologyNanopore Sequencing, Single-Molecule Real-Time Sequencing, Synthetic Long-Read Sequencing
ComponentHardware, Software, Reagents
ApplicationClinical Diagnostics, Drug Discovery, Agricultural and Animal Research, Forensics
End UserPharmaceutical Companies, Biotechnology Companies, Research Institutes, Academic Institutions
DevicePortable Sequencers, Benchtop Sequencers
ProcessLibrary Preparation, Sequencing, Data Analysis
StageResearch and Development, Clinical Trials, Commercial Deployment

Geographical Overview:

The 5th Generation DNA Sequencing Market is witnessing varied growth patterns across regions, each characterized by unique attributes. North America leads the market, driven by substantial investments in genomic research and advanced healthcare infrastructure. The presence of key industry players further accelerates market growth, fostering innovation and technological advancements. Europe follows closely, with significant investments in biotechnology and genomics. The region's strong regulatory framework and emphasis on research and development contribute to a thriving market environment. Collaborative initiatives between academic institutions and industry players enhance the market's potential. In the Asia Pacific, the market is expanding rapidly, propelled by increasing government funding and a growing interest in precision medicine. Countries like China and India are at the forefront, investing in state-of-the-art sequencing technologies to support their burgeoning healthcare sectors. Latin America is emerging as a promising market, with rising healthcare investments and a growing focus on genomic research. The region's increasing awareness of personalized medicine drives demand for advanced sequencing technologies, opening new avenues for growth. The Middle East & Africa are also recognizing the potential of 5th Generation DNA Sequencing. Governments are investing in healthcare infrastructure and research initiatives, aiming to harness the benefits of genomic technologies. These efforts are paving the way for future market expansion.

Recent Developments:

The 5th Generation DNA Sequencing Market has witnessed notable developments in recent months. Illumina announced a strategic partnership with a leading biotech firm to enhance its sequencing technology, aiming to accelerate genomic research and clinical applications. Thermo Fisher Scientific unveiled a breakthrough in sequencing technology, promising faster and more accurate results, which could revolutionize personalized medicine. Pacific Biosciences completed the acquisition of a smaller tech company specializing in advanced sequencing algorithms, strengthening its position in the competitive landscape. Meanwhile, Oxford Nanopore Technologies launched a new sequencing platform designed for real-time analysis, catering to the growing demand for rapid genomic insights. In regulatory news, the European Medicines Agency updated its guidelines to streamline the approval process for new sequencing technologies, potentially expediting market entry for innovative solutions. These events underscore the dynamic nature of the 5th Generation DNA Sequencing Market, highlighting significant advancements and strategic maneuvers by key players.

Key Companies:

Oxford Nanopore Technologies, Pacific Biosciences, BGI Genomics, Genapsys, Quantum-Si, Element Biosciences, Ultima Genomics, Stratos Genomics, Roswell Biotechnologies, SeqLL, DNA Electronics, Helicos BioSciences, Tessera Therapeutics, Genoox, Arbor Biosciences, Molecular Assemblies, Evonetix, Twist Bioscience, Base4 Innovation, Microsynth

Key Trends and Drivers:

The 5th Generation DNA Sequencing Market is experiencing robust expansion fueled by technological advancements and increasing demand for precision medicine. A key trend is the integration of artificial intelligence, which enhances data analysis and interpretation, leading to more accurate and efficient sequencing results. The decline in sequencing costs is making technology accessible to a broader range of research institutions and clinical settings, thereby accelerating adoption. The rise of personalized medicine is a significant driver, as it necessitates precise genetic information to tailor treatments to individual patients. This demand is propelling research and development investments in DNA sequencing technologies. Additionally, the growing prevalence of genetic disorders and cancer is intensifying the need for advanced sequencing solutions, further stimulating market growth. Opportunities abound in emerging markets where healthcare infrastructure is rapidly developing. Companies that can provide affordable and scalable sequencing solutions are well-positioned to capture market share in these regions. Furthermore, collaborations between academic institutions and industry players are fostering innovation, driving the development of next-generation sequencing platforms. With the ongoing emphasis on genomics in healthcare, the 5th Generation DNA Sequencing Market is poised for sustained growth.

Key Restraints and Challenges:

The 5th Generation DNA Sequencing Market faces several notable restraints and challenges. A primary restraint is the exorbitant cost of sequencing technologies, which hampers widespread adoption, particularly in developing regions. Furthermore, the complexity of data interpretation demands specialized skills, creating a bottleneck in the practical application of sequencing results. Regulatory hurdles also pose a significant challenge, as navigating the intricate landscape of compliance and approvals can delay market entry and increase operational costs. Additionally, concerns regarding data privacy and security deter potential users, as the sensitive nature of genetic information requires robust safeguards. Finally, the rapid pace of technological advancements can render existing systems obsolete, necessitating continuous investment and adaptation, which can be a daunting prospect for many organizations. These factors collectively constrain the growth and accessibility of the 5th Generation DNA Sequencing Market.

Sources:

National Institutes of Health (NIH) - National Human Genome Research Institute, European Molecular Biology Laboratory (EMBL), U.S. Food and Drug Administration (FDA), Genome Canada, Wellcome Trust Sanger Institute, European Commission - Directorate-General for Research and Innovation, Human Genome Organisation (HUGO), Genomics England, U.S. National Library of Medicine - National Center for Biotechnology Information (NCBI), International Society for Computational Biology, American Society of Human Genetics, International Conference on Genomics, Cold Spring Harbor Laboratory - Genome Research, European Society of Human Genetics, National Genomics Data Center (China), Global Alliance for Genomics and Health (GA4GH), International Congress of Human Genetics, University of California, Santa Cruz - Genomics Institute, National Health Service (NHS) Genomic Medicine Service, International Symposium on Bioinformatics Research and Applications

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: 5th Generation DNA Sequencing Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: 5th Generation DNA Sequencing Market Outlook

5: 5th Generation DNA Sequencing Market Strategy

6: 5th Generation DNA Sequencing Market Size

7: 5th Generation DNA Sequencing Market, by Type

8: 5th Generation DNA Sequencing Market, by Product

9: 5th Generation DNA Sequencing Market, by Services

10: 5th Generation DNA Sequencing Market, by Technology

11: 5th Generation DNA Sequencing Market, by Component

12: 5th Generation DNA Sequencing Market, by Application

13: 5th Generation DNA Sequencing Market, by End User

14: 5th Generation DNA Sequencing Market, by Device

15: 5th Generation DNA Sequencing Market, by Process

16: 5th Generation DNA Sequencing Market, by Stage

17: 5th Generation DNA Sequencing Market, by Region

18: Competitive Landscape

19: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기